Background The interaction between motivation to eat, eating behaviour traits and gut
Introduction
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Currently bariatric surgery is becoming routinely integrated into the management of morbidly obese patients 1 . The intended outcome of bariatric surgery is a reduction in excess weight and improvement of co-morbidities. The average long term excess weight reduction following surgery is 50% 2 . The achievement of such a success requires dramatic modification of behaviour and associated eating patterns 3 . Roux-en-Y gastric bypass
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(RYGB) alters levels of circulating appetite peptides 4, 5 , but the association of such physiological changes with the subsequent expression of motivations to eat and eating behaviour traits is less well known.
It is expected that RYGB surgery will force a change in eating behaviour, leading to weight 35 loss. This change is expected to occur within short-term, episodic eating behaviour patterns (within a meal and over a day) as well as affecting eating patterns over a longer time frame (eating behaviour traits). Indeed, alternations in levels of circulating peptides known to be involved in episodic (glucagon-like peptide-1 (GLP-1), ghrelin) and tonic (leptin) control of appetite are seen. For example, Falkén et al., 5 found that circulating levels of GLP-1 levels 40 increased as early as three days following surgery, and were associated with a decreased subjective hunger rating. Furthermore, a decrease in levels of ghrelin post-surgery has been
shown to be associated with lower hunger ratings 6 . On the other hand, leptin levels decrease following surgery 7 which in turn could affect the tonic processes involved in appetite control. These changes in appetite peptides (except for leptin) favour an anorectic response,
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which is reflected in the patients' subjective appetite sensations. These effects occur immediately following surgery and persist for at least 12 months.
In addition, a change in eating behaviour trait profiles has also been found to occur in response to gastric surgery as measured by the Three Factor Eating Questionnaire 18
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(TFEQR18) 8 . The TFEQ measures Cognitive Restraint (CR: limiting food intake in order to control weight), Uncontrolled Eating (UE: eating in response to external cues) and Emotional Eating (EE: eating in response to negative affect). A reduction in UE and EE, but no change in CR has been reported in response to RYGB surgery 9 .
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Gut peptide data and effects on glucose homeostasis from this study have been published previously 5 . The aim of this study was to assess the relationship between TFEQR18, weight loss, motivation to eat and appetite peptides in patients undergoing RYGB and if these changes are associated with alternations in levels of tonic (leptin) and episodic appetite peptides (ghrelin, insulin and GLP-1).
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Method
Participants
Fourteen participants were recruited to take part in this study. Two participants were removed from the analysis due to incomplete data. Therefore twelve, non-diabetic obese participants (BMI 45.3 ± 1.9 kg/m2, mean age 36 ± 2 years, 3 men) completed the study. All participants gave oral and written consent. Participants received standard dietary advice before surgery and were seen by the dietician 6 months after surgery. The study was approved by the regional Ethics Committee of Stockholm.
Design
The patients were studied prospectively before and at 3 days, 2 months and one year following a standard laparoscopic, RYGB with a 1-metre Roux-limb. On test days,
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participants consumed a fixed liquid pre-load (200ml, ProvideXtra, Fresenius Kabi AB, Uppsala, Sweden, 300 kcal, fat (0%), protein (11%) and carbohydrates (89%)) following an overnight fast. Peptides and appetite were measured immediately before the pre-load, and periodically (10, 20, 30, 60, 90, 120 and 180 min) after. The TFEQR18 was also completed on the morning of each study day.
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Peptides
Blood samples were collected in pre-chilled EDTA tubes. Samples were centrifuged at 4 C for 10 minutes at 3000 rpm. Plasma samples were collected and stored at -20C until analysis in a single run. Detailed description of assays can be found in Falkén et al (5).
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Insulin was measured with a human insulin specific radioimmunoassay (RIA) kit (HI-14HK, Millipore, Billerica, MA, USA). The sensitivity and detection limit of the RIA was 2 μU/L and coefficient of variation below 4% (100 μU/L).
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Leptin was measured with the human leptin specific RIA kit (EZHL-80SK, Millipore, Billerica, MA, USA). The detection limit and sensitivity of the assay is 0.5 ng/mL with a variation coefficient of less than 4.6% (22.1 ng/mL).
Ghrelin (total) was measured with ELISA (EZGRT-89K, Millipore, Billerica, MA, USA),
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which was standardized in our laboratory. As calibrator for the assay a lyophilized ghrelin standard was used. The detection limit of the assay was 27 pmol/L and variation coefficient 10% (300 pmol/L) and 4% (900 pmol/L).
GLP-1 was measured using RIA against a standard of synthetic GLP-1(7-36) amide using 100 antiserum code no. 89390, specific for the amidated C-terminus of GLP-1. This assay displays equal avidity to intact GLP-1 and GLP-1(9-36) amide, its primary metabolite. The sensitivity and detection limit were below 1 pmol/L and intra-assay coefficient of variation below 6% at 20 pmol/L 10 .
105
Appetite ratings
Subjective appetite sensations were measured using 100 mm visual analogue scales (VAS)
anchored with "not at all" and "extremely". Appetite sensations were assessed by questions relating to hunger, fullness and desire to eat.
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TFEQR18
The TFEQR18 8 is a modified version of the 51-item TFEQ 11 . The 18-item scale measures three factors; Restraint (cognitive restriction of food intake to control body weight), Uncontrolled Eating (UE: excessive appetite and external eating) and Emotional Eating (EE:
eating in response to negative affect). Seventeen items are answered on a four point Likert
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scale anchored with "definitely true" to "definitely false", while one item uses an eight point Likert scale. Scores are summed and transformed to a scale of 1-100. The TFEQR18 has acceptable criterion and discriminant validity and internal consistency 8, 12 .
Statistical analysis
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Data were analysed via repeated measures ANOVA to discern any change in motivation to eat, TFEQR18 factors and peptide levels (fasting, intra-meal change and AUC). Intra-meal 
Results
Changes from pre to one-year post surgery
There was a significant decrease in body weight (F (3, 33) = 255.33, p<0.001) and BMI (F (3,33) = 278.78, p<0.001: see Table 1 ). There was also a significant decrease in EE (F (3, 24) = 3.71, p = 0.025) and UE (F (3, 24) = 12.73, p<0.001). There was no significant change in CR. Table 2 ). An increase in fasting ghrelin (F (3,30) = 3.94, p = 0.18), and decreases in fasting leptin (F (3,33) = 2.59, p<0.001) and insulin (F (3,33) = 4.77, p = 0.007) were observed. However, there was no significant change in fasting GLP-1 (see Table 3 for peptide profiles). There were no significant changes in intra-meal levels of ghrelin, however, there was a significant increase in intra-meal insulin (F (3,33) = 27.21, p<0.001) and GLP-1 (F (3,33) = 145 7.98, p<0.001: see Table 2 ). Table 2 one year after surgery was found (see Table 2 ). There were no significant changes in fasting ratings of desire to eat, fullness or hunger or changes in intra-meal appetite ratings from preto one year post surgery. 
Relationship amongst the variables at baseline
Baseline body weight was not associated with any baseline TFEQR18 factors, ratings of motivation to eat or appetite peptides, with the exception of insulin. Both fasting and AUC insulin were associated with baseline weight (r = 0.89, p<0.001; r = 0.66, p = 0.021, respectively). Upon examination of the associations between pre-surgery TFEQR18 and peptide levels, there was a correlation between EE and fasting ghrelin (r = .84, p = 0.005) and a marginal association between UE and fasting leptin (r = .65, p = 0.056). In addition, there was an association between EE and ghrelin AUC (r = .83, p = 0.006).
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In terms of the relationship between motivation to eat and TFEQR18 factors, a significant association between desire to eat AUC and UE (r = .67, p = 0.047) was found. Two months following surgery there was a negative correlation between AUC desire to eat and CR (r = - 
Discussion
This study has demonstrated that TFEQR18 factors of EE and UE significantly decrease 210 following gastric by-pass surgery, but that Restraint remains stable. These changes are congruous with alterations, which occurred in subjective appetite ratings and in levels of appetite peptides. To our knowledge, this is the first paper to assess relationships amongst the TFEQR18 factors, subjective appetite and appetite peptides in obese patients undergoing RYGB surgery.
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Previous research has used the original TFEQ to assess eating behaviour traits pre-and postgastric weight loss surgery. This research demonstrated that in response to weight loss induced by gastric surgery (both gastric band and gastric bypass), a reduction in Disinhibition and Hunger and increase in Restraint are seen [13] [14] [15] [16] [17] . Within this study, a significant reduction 220 in UE and EE was seen over a year following gastric by-pass surgery, with no change in Restraint observed, which is in line with findings from Laurenius et al. 9 The factors of UE and EE are comprised of Hunger and Disinhibition items, thus the decrease is in line with previous findings and reflect a reduction in susceptibility to overeat. What is interesting is the lack of change in Restraint. This pattern was also observed by Karlsson et al., 17 and
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Laurenius et al., 9 who found a return towards baseline values of TFEQ factors after gastric surgery. However, despite movement towards baseline levels, the change in TFEQR18 traits from pre-to post-surgery, do show an eating behaviour trait profile, which promotes weight regulation.
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The mechanism behind the change in eating behaviour traits remains to be elucidated.
However, a relationship between appetite peptides and eating behaviour traits, both pre-and post-operatively was established. The finding in this study of a relationship between ghrelin (fasting and AUC) and UE and EE, independently of BMI, supports previous findings of a significant association between fasting ghrelin and TFEQ Disinhibition 18 and TFEQ Hunger 235 6 . As ghrelin is associated with a hyperphagic response 19 it is congruous that it is associated with UE and EE which both represent a propensity to overeat 8, 20 . This is an important finding as it supports the notion that psychological eating behaviour traits are, at least in part, underpinned by appetite peptides.
240
The changes in eating behaviour traits represent a tonic response of subjective appetite regulation following RYGB. The more episodic subjective response was assessed using VAS.
The regulation of appetite in response to the liquid meal from pre-to post-surgery showed an improvement in appetite profiles with a reduced hunger and desire to eat and increased fullness following surgery. Desire to eat was positively associated with ghrelin (fasting and 245 AUC), while fasting GLP-1 was negatively associated with desire to eat and positively with fullness. The relationship between peptides and subjective appetite response could at least in part explain the mechanism behind the sustained weight loss following bariatric surgery.
Furthermore, the episodic subjective appetite ratings are also related to the TFEQR18 factors.
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UE was related to desire to eat pre-surgery and hunger post-surgery. It is plausible that the association of UE with heightened appetite ratings could be the expression of the tonic UE trait in the short term. In line with this, EE has been associated with increased consumption of sweet foods 21 , and both UE and EE have been associated with obesity and lower levels of self-control 20 , supporting the relationship between heightened episodic appetite responses to 255 more enduring eating behaviour traits.
In conclusion, this study has demonstrated that TFEQR18 factors of EE and UE significantly decrease following RYGB surgery, but that Restraint remains stable. Although these changes
were not significantly associated with weight loss, they were significantly associated with 260 appetite peptides and subjective appetite ratings. This study suggests that there are biological mechanisms underpinning the expression of tonic and episodic subjective appetite sensations.
In addition, it is apparent that these peptide changes can, at least partially, explain the changes seen in eating behaviour traits following RYGB surgery. There are several limitations to this study however. The sample size was small and the participants were only 
